Daily Signals
2487 companies scored · 2026-10-14 run in progress: 2176 of ~5379 signals so far · Alpha · vs marketSwitch to Total · 30D 90D
Distribution of the day's forecasts
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
288 companies
Sorted by market cap ↓ · forecast rankings are part of the paid plans
| Ticker | Rating | 90D | Δ | |
|---|---|---|---|---|
| DNAGinkgo Bioworks Holdings, Inc. | Unlock rating and forecasts | |||
| CRVSCorvus Pharmaceuticals, Inc. | Unlock rating and forecasts | |||
| ARDXARDELYX, INC. | Unlock rating and forecasts | |||
| GERNGERON CORP | Unlock rating and forecasts | |||
| GYREGYRE THERAPEUTICS, INC. | Unlock rating and forecasts | |||
| ANNXAnnexon, Inc. | Unlock rating and forecasts | |||
| SANASana Biotechnology, Inc. | -0.02% | · | ||
| ACHVACHIEVE LIFE SCIENCES, INC. | -0.01% | · | ||
| LXRXLEXICON PHARMACEUTICALS, INC. | Unlock rating and forecasts | |||
| CADLCandel Therapeutics, Inc. | Unlock rating and forecasts | |||
| COLLCOLLEGIUM PHARMACEUTICAL, INC | -0.20% | · | ||
| FDMT4D Molecular Therapeutics, Inc. | Unlock rating and forecasts | |||
| VSTMVerastem, Inc. | Unlock rating and forecasts | |||
| ZVRAZEVRA THERAPEUTICS, INC. | Unlock rating and forecasts | |||
| AURAAura Biosciences, Inc. | Unlock rating and forecasts | |||
| SLDBSolid Biosciences Inc. | Unlock rating and forecasts | |||
| IMMXImmix Biopharma, Inc. | Unlock rating and forecasts | |||
| WVEWave Life Sciences, Inc. | -0.48% | · | ||
| OLMAOlema Pharmaceuticals, Inc. | Unlock rating and forecasts | |||
| DSGNDesign Therapeutics, Inc. | Unlock rating and forecasts | |||
| PRMEPrime Medicine, Inc. | Unlock rating and forecasts | |||
| IRWDIRONWOOD PHARMACEUTICALS INC | Unlock rating and forecasts | |||
| CLYMClimb Bio, Inc. | Unlock rating and forecasts | |||
| AQSTAquestive Therapeutics, Inc. | Unlock rating and forecasts | |||
| CRMDCorMedix Inc. | Unlock rating and forecasts | |||
| PHATPhathom Pharmaceuticals, Inc. | Unlock rating and forecasts | |||
| IVAInventiva S.A. | Unlock rating and forecasts | |||
| STTKShattuck Labs, Inc. | Unlock rating and forecasts | |||
| EOLSEvolus, Inc. | Unlock rating and forecasts | |||
| ACRSAclaris Therapeutics, Inc. | Unlock rating and forecasts | |||
| CTMXCytomX Therapeutics, Inc. | Unlock rating and forecasts | |||
| SGMTSagimet Biosciences Inc. | +0.35% | · | ||
| MNPRMonopar Therapeutics | Unlock rating and forecasts | |||
| RGNXREGENXBIO Inc. | Unlock rating and forecasts | |||
| ENTXEntera Bio Ltd. | Unlock rating and forecasts | |||
| ADXNAddex Therapeutics Ltd. | +0.19% | · | ||
| ARVNARVINAS, INC. | -0.02% | · | ||
| ALLOAllogene Therapeutics, Inc. | Unlock rating and forecasts | |||
| TLRYTilray Brands, Inc. | Unlock rating and forecasts | |||
| TKNOAlpha Teknova, Inc. | Unlock rating and forecasts | |||
| NGNENeurogene Inc. | Unlock rating and forecasts | |||
| NIKANIKA PHARMACEUTICALS, INC | Unlock rating and forecasts | |||
| AUTLAutolus Therapeutics plc | Unlock rating and forecasts | |||
| PRTAPROTHENA CORP PUBLIC LTD CO | -0.11% | · | ||
| OVIDOvid Therapeutics Inc. | Unlock rating and forecasts | |||
| TECXTectonic Therapeutic, Inc. | Unlock rating and forecasts | |||
| ASMBASSEMBLY BIOSCIENCES, INC. | +0.15% | · | ||
| ZURAZura Bio Ltd | Unlock rating and forecasts | |||
| SPRYARS Pharmaceuticals, Inc. | +0.05% | · | ||
| CAPRCAPRICOR THERAPEUTICS, INC. | Unlock rating and forecasts | |||
By sector
Median 90D forecast per sector. Click to filter.
Rating changes
Unlock the full ranking
Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.
See plans Create a free accountRatings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.